Kavita Nanda, MD, MHS, Mpanoratra ao amin'ny Knowledge SUCCESS

Kavita Nanda, MD, MHS

Director of Medical Research, Product Development and Introduction, FHI 360

Kavita Nanda, MD, MHS, Director of Medical Research, FHI 360, is an obstetrician/gynecologist who has devoted her career to developing and improving the use of contraceptive methods for women. She was a co-investigator and chair of the contraceptive-safety committee for the Evidence for Contraceptive Options (ECHO) trial, a multicenter randomized trial of three different contraceptives and HIV acquisition in 7,800 African women at high risk of HIV. Dr. Nanda has served as the principal investigator for several FHI 360 studies, including addressing the safety of hormonal contraceptives among women with various medical conditions, and as study medical director for several large HIV prevention trials. Currently, Dr. Nanda is the director of a program to develop a new biodegradable implant for contraception funded by the Bill and Melinda Gates Foundation.

DMPA-IM, 2-rod levonorgestrel implant, ary ny IUD varahina. Photo credit: Leanne Gray

Vakio haingana Asa tsy vita ho an'ny fidirana amin'ny fanabeazana aizana sy ny fisorohana ny VIH

Timoty D. tompony, MD, DTM&HKavita Nanda, MD, MHS Janoary 28, 2021

Findings from the ECHO trial led to an increased focus in HIV prevention in family planning programs. Here's what else needs to happen in the COVID-19 context.

0 fanehoan-kevitra 17654 hevitra

Makà kaopy kafe na dite ary henoy ny resadresaka marina miaraka amin'ireo manam-pahaizana momba ny fandaharan'asan'ny fandrindram-pianakaviana manerana izao tontolo izao rehefa mizara izay nandaitra tao amin'ny toerana misy azy izy ireo — sy izay tokony hohalavirina — ao amin'ny andian-dahatsoratray podcast., Ao anatin'ny tantara FP.

Kitiho ny sary etsy ambony raha hitsidika ny pejin'ny podcast na amin'ny mpamatsy tianao eto ambany raha hihaino ny Inside the FP Story.